Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles
-
- Charles A. Specht
- Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
-
- E. Jane Homan
- ioGenetics LLC, Madison, Wisconsin, USA
-
- Chrono K. Lee
- Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
-
- Zhongming Mou
- Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
-
- Christina L. Gomez
- Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
-
- Maureen M. Hester
- Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
-
- Ambily Abraham
- Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
-
- Florentina Rus
- Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
-
- Gary R. Ostroff
- Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
-
- Stuart M. Levitz
- Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA
-
- Tamara L. Doering
- editor
抄録
<jats:p>Cryptococcosis, due to infection by fungi of the<jats:named-content content-type="genus-species">Cryptococcus neoformans</jats:named-content>species complex, is responsible for substantial morbidity and mortality in immunocompromised persons, particularly those with AIDS. Cryptococcal vaccines are a public health priority yet are not available for human use.</jats:p>
収録刊行物
-
- mBio
-
mBio 13 (1), 2022-02-22
American Society for Microbiology